Form 8-K - Current report:
SEC Accession No. 0000917520-20-000002
Filing Date
2020-01-14
Accepted
2020-01-14 16:57:14
Documents
15
Period of Report
2020-01-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8kfiledjan142020.htm   iXBRL 8-K 50390
2 EXHIBIT 99.1 pressreleasejan142020.htm EX-99.1 21799
  Complete submission text file 0000917520-20-000002.txt   210792

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT iart-20200114.xsd EX-101.SCH 4638
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT iart-20200114_cal.xml EX-101.CAL 675
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT iart-20200114_def.xml EX-101.DEF 1525
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT iart-20200114_lab.xml EX-101.LAB 23061
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT iart-20200114_pre.xml EX-101.PRE 12107
13 EXTRACTED XBRL INSTANCE DOCUMENT a8kfiledjan142020_htm.xml XML 3963
Mailing Address 1100 CAMPUS ROAD PRINCETON NJ 08540
Business Address 1100 CAMPUS ROAD PRINCETON NJ 08540 6092750500
INTEGRA LIFESCIENCES HOLDINGS CORP (Filer) CIK: 0000917520 (see all company filings)

EIN.: 510317849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26224 | Film No.: 20526508
SIC: 3841 Surgical & Medical Instruments & Apparatus